Excellere Partners has completed an investment in Biocare Medical. The Northern California based company is a leading provider of immunohistochemistry (IHC) instrumentation, as well as a full range of reagents for IHC and molecular testing. Biocare is a market leader in simultaneous Multiplex IHC tests, which provide increased confidence at critical diagnostic decision points, improving patient therapy while accelerating turnaround time. Biocare’s existing management will continue to run the company and maintained a significant equity position in the ongoing business.